Biotech as a future, but above all as a present. The revolution to build a healthier and more sustainable future has started and biotechnology is being applied in many areas.
This is the topic of the 2019 Assembly of Assobiotec, held in Rome on May 16th, 2019, which discussed what biotech can do for Italy.
Three case histories were chosen to describe the brilliant contribution of national biotech innovation. Next to Catia Bastioli, Novamont CEO, Rino Rappuoli, Chief Scientist & Head of External R&D GSK Vaccines, they presented the video-testimony of Elena Sgaravatti, DemBiotech® CEO.